cell-therapy

Documents about cell-therapy

• Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026#353872Europe PMC
• Advances in natural killer cell immunotherapy for hematologic malignancies#205417Europe PMC
• Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy#864068ClinicalTrials.gov
• Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1#827161ClinicalTrials.gov
• Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy#307466ClinicalTrials.gov
• The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions#651926Europe PMC
• Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and Enhancing Efficacy of CAR-T Cell Therapy#844493ClinicalTrials.gov
• Dendritic Cell Based Therapy of Renal Cell Carcinoma#807650ClinicalTrials.gov
• Stem Cell Therapy for Cerebral Palsy#851771ClinicalTrials.gov
• Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma#800388ClinicalTrials.gov
• Vaccine Responsiveness After CAR-T Cell Therapy#201619ClinicalTrials.gov
• PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma#863411ClinicalTrials.gov
• Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer#481756ClinicalTrials.gov
• Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy#448261ClinicalTrials.gov
• Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation#146441ClinicalTrials.gov
• Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma#674900ClinicalTrials.gov
• Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma#338805OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma#846037ClinicalTrials.gov
• Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial#830211ClinicalTrials.gov
• CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01#833317ClinicalTrials.gov
• Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia#865549ClinicalTrials.gov
• Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry#642695Europe PMC
• CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas#195329ClinicalTrials.gov
• South America and Mexico's cell and gene therapy landscape: accelerating growth and persistent challenges.#419063PubMed
• Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer#828003ClinicalTrials.gov
• Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma#387160ClinicalTrials.gov
• A Deep‐Red‐Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death#175722HAL (France)
• Cell therapy in multiple sclerosis: An overview#147484HAL (France)
• CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.#160363ClinicalTrials.gov
• Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC)#162484ClinicalTrials.gov
• T Cell Therapy of Opportunistic Cytomegalovirus Infection#325312ClinicalTrials.gov
• Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy#623509ClinicalTrials.gov
• Stem cell strategies for cell replacement therapy in endocrine diseases.#645427NCBI PubMed Central
• Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial#640570ClinicalTrials.gov
• Targeted delivery of mRNA to immune cells for <i>in vivo</i> cell therapy#676323Europe PMC
• INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer#826384ClinicalTrials.gov
• Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma#834701ClinicalTrials.gov
• Targeted Therapy and Avelumab in Merkel Cell Carcinoma#325300ClinicalTrials.gov
• From technological iteration to clinical breakthrough: advances of CAR-T cell therapy in autoimmune diseases#4648Europe PMC
• Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma#180376ClinicalTrials.gov
• Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer#825620ClinicalTrials.gov
• Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy#839587ClinicalTrials.gov
• EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation#801648ClinicalTrials.gov
• A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome#805975ClinicalTrials.gov
• Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study#184829ClinicalTrials.gov
• CAR-Mast Cell Therapy for Solid Tumor#256652EliScholar
• Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis#807974ClinicalTrials.gov
• 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.#230426ClinicalTrials.gov
• Targeting ZC3H12C improves T cell persistence and antitumor function in adoptive T cell therapy#243486bioRxiv / medRxiv
• Study of CAR-T Therapy in Older Patients#858191ClinicalTrials.gov